Cargando…

Advanced case of PKDL due to delayed treatment: A rare case report

Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral leishmaniasis (VL) and is thought to be the potential reservoir of parasite. Miltefosine (MF) is the only oral drug existing for treatment of post-kala-azar dermal leishmaniasis (PKDL). Increased miltefosine tolerance in clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topno, Roshan Kamal, Rabi Das, Vidya Nand, Kumar, Maneesh, Madhukar, Major, Pandey, Krishna, Verma, Neena, Agrawal, Kanhaiya, Lal, Chandra Shekhar, Siddiqui, Niyamat Ali, Bimal, Sanjiva, Das, Pradeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Symposium
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089400/ https://www.ncbi.nlm.nih.gov/pubmed/32203500 http://dx.doi.org/10.1371/journal.pntd.0008052

Ejemplares similares

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
por: Rabi Das, Vidya Nand, et al.
Publicado: (2017)

Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study
por: Verma, Neena, et al.
Publicado: (2015)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
por: Das, Vidya Nand Rabi, et al.
Publicado: (2020)

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2016)

Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
por: Pandey, Krishna, et al.
Publicado: (2020)

Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2021)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2009)

Tuberous sclerosis with visceral leishmaniasis: a case report
por: Pandey, Krishna, et al.
Publicado: (2009)

HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report
por: Pandey, Krishna, et al.
Publicado: (2008)

Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report
por: Marking, Ulrika, et al.
Publicado: (2014)

Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India
por: Garapati, Pavan, et al.
Publicado: (2018)

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal
por: Joshi, Anand Ballabh, et al.
Publicado: (2023)

Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients
por: SINGH, Ashish Kumar, et al.
Publicado: (2018)

Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison
por: Siddiqui, Niyamat A., et al.
Publicado: (2016)

Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
por: Dikhit, Manas Ranjan, et al.
Publicado: (2017)

Assessment of quality of life in patients with post kalaazar dermal leishmaniasis
por: Pal, Biplab, et al.
Publicado: (2017)

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
por: Sundar, Shyam, et al.
Publicado: (2014)

The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
por: Dikhit, Manas Ranjan, et al.
Publicado: (2018)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases
por: Das, Dilip K.
Publicado: (2018)

Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani
por: Kumari, Anjali, et al.
Publicado: (2017)

Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2014)

Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study
por: Das, Sushmita, et al.
Publicado: (2016)

The immunology of post-kala-azar dermal leishmaniasis (PKDL)
por: Zijlstra, Eduard E.
Publicado: (2016)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2020)

Kala-azar elimination in a highly-endemic district of Bihar, India: A success story
por: Kumar, Vijay, et al.
Publicado: (2020)

Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh
por: Mondal, Dinesh, et al.
Publicado: (2010)

Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients
por: Vijayamahantesh,, et al.
Publicado: (2016)

Totally extraperitoneal repair of inguinal hernia: A case for bilateral repair
por: Chowbey, Pradeep K, et al.
Publicado: (2006)

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2018)

Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
por: Adams, Emily R., et al.
Publicado: (2013)

Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis
por: Veeri, Rajendra Babu, et al.
Publicado: (2019)

Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress
por: Singh, Kuljit, et al.
Publicado: (2017)

Three-Dimensional Optical Scanning in Post–kala-azar Dermal Leishmaniasis (PKDL)
por: Zijlstra, Eduard E., et al.
Publicado: (2020)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

An overview of QTc Prolongation with antipsychotics and antidepressants
por: Bhandari, Samrat Singh, et al.
Publicado: (2022)

Dermatoscopy of Infections and Infestations
por: Chatterjee, Manas, et al.
Publicado: (2021)

Morphology, epidemiology, and phylogeny of Babesia: An overview
por: Laha, Ramgopal, et al.
Publicado: (2015)

Microalbuminuria and Glomerular Filtration Rate in Paediatric Visceral Leishmaniasis
por: Verma, Neena, et al.
Publicado: (2013)

Diagnosis of Visceral Leishmaniasis in Bihar India: Comparison of the rK39 Rapid Diagnostic Test on Whole Blood Versus Serum
por: Matlashewski, Greg, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c2koc39bkkq3pqabjcd57fbh23